| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53b4d53983adbf56dd0e7d0bf96f8ce5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1da4d78f322f477afffa4c97017c91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11035f803ecbcde1da343f243899458a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c1573be61f096ce0bac1aad05a4a0f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f5c1e33262d05ee893b3f93d89f01a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893a4b376a278203b039630a6c435852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfa6410fb4d812ea15f910f4e0666f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f045690c1320e5bf8515a82365c748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75e660d37ebeec506196dfa13f60d7ed |
| publicationDate |
2021-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113214377-A |
| titleOfInvention |
A kind of antimicrobial peptide AP-64 and its preparation method and use |
| abstract |
The invention discloses an antibacterial peptide AP-64 and a preparation method and use thereof. The antibacterial peptide AP-64 is a polypeptide and contains 64 amino acids; the preparation method includes the following steps: recombinantly expressing a nucleic acid sequence containing human AP-64. The plasmid was transformed into engineered Escherichia coli Rosseta competent cells; single clone was expanded and induced to express; affinity chromatography; anion exchange. The invention has the function of resisting gram-negative pathogenic bacteria, and has great potential application value in inhibiting the growth, reproduction and dissemination of microorganisms and preventing or treating pathogenic microorganism infection. |
| priorityDate |
2020-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |